Herspiegel’s Playbook for Navigating Loss of Exclusivity Through Commercial Levers provides pharmaceutical leaders with a comprehensive framework to address LOE strategically. Get the whitepaper now.
Patient Support Programs (PSPs) have become essential in bridging the gap between pharmaceutical companies and patients, ensuring access, affordability, and adherence to therapies. Get the whitepaper now.
In this whitepaper, you will discover:
The four most common challenges in cell and gene therapy commercialization. Methods to address common product launch challenges. Insights to accelerate and de-risk launch for cell and gene therapy treatments. Read more.
The IRA will make many improvements to the Medicare program overall, and many on the pharmaceutical side have been mainly focused on preparing for the Medicare Drug Price Negotiation Program. Download this paper to understand the current timelines and guidance.
